Andlauer Healthcare Group Inc. (TSE:AND – Get Rating) – Stock analysts at National Bank Financial have raised their earnings per share (EPS) estimates for fiscal year 2022 for Andlauer Healthcare Group in a report released Thursday, March 3 . National Bank Financial analyst E. Leno now expects the company to post earnings of $1.51 per share for the year, up from its previous forecast of $1.47. . National Bank Financial also released earnings estimates for Andlauer Healthcare Group’s fiscal year 2023 at $1.58 EPS.
DNA has been the subject of several other research reports. Scotiabank raised its target price on Andlauer Healthcare Group from C$51.00 to C$54.00 in a research note on Friday. TD Securities downgraded Andlauer Healthcare Group from a “buy” rating to a “hold” rating and set a target price of C$55.00 for the stock. in a research note from Wednesday, January 5. CIBC raised its target price on Andlauer Healthcare Group from C$54.00 to C$56.00 in a research note on Friday. National Bankshares raised its price target on Andlauer Healthcare Group from C$49.00 to C$49.50 and gave the company an “industry performance” rating in a research report on Friday. Finally, Royal Bank of Canada cut its price target on Andlauer Healthcare Group from CA$56.00 to CA$52.00 and set an “sector performance” rating on the stock in a research report on Friday. . Five investment analysts gave the stock a holding rating. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of C$51.00.
ET opened at CA$48.25 on Monday. The stock’s 50-day moving average price is C$49.34 and its 200-day moving average price is C$48.43. Andlauer Healthcare Group has a 12-month low of C$34.53 and a 12-month high of C$55.84. The company has a current ratio of 1.23, a quick ratio of 1.16 and a debt ratio of 127.26. The company has a market capitalization of C$2.02 billion and a price-to-earnings ratio of 37.17.
In other news, senior officer Stephen Barr sold 5,000 shares of the company in a trade dated Friday, December 24. The stock was sold at an average price of CA$54.40, for a total transaction of CA$272,000.00. As a result of the sale, the insider now owns 12,952 shares of the company, valued at approximately C$704,588.80.
The company also recently announced a quarterly dividend, which was paid on Monday, January 17. Shareholders of record on Friday, December 31 received a dividend of $0.05 per share. This represents an annualized dividend of $0.20 and a dividend yield of 0.41%. The ex-dividend date was Thursday, December 30. Andlauer Healthcare Group’s dividend payout ratio (DPR) is currently 15.41%.
Andlauer Healthcare Group Company Profile (Get a rating)
Andlauer Healthcare Group Inc, a supply chain management company, provides customized third-party logistics (3PL) platform and specialized transportation solutions for the healthcare industry in Canada. It operates in two segments, specialized transportation and healthcare logistics. The company provides specialized temperature-controlled services; and ground transportation services, including LTL and courier services; and air freight transit, and dedicated and last mile delivery services.
This instant news alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Should you invest $1,000 in Andlauer Healthcare Group right now?
Before you consider Andlauer Healthcare Group, you’ll want to hear this.
MarketBeat tracks Wall Street’s top-rated, top-performing research analysts daily and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and Andlauer Healthcare Group was not on the list.
While Andlauer Healthcare Group currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the 5 actions here